ImportRefusal LogoImportRefusal

Biologic Pharmamedical Research

⚠️ Moderate Risk

FEI: 3016850308 • Surrey, British Columbia • CANADA

FEI

FEI Number

3016850308

📍

Location

Surrey, British Columbia

🇨🇦

Country

CANADA
🏢

Address

688-2397 King George Blvd, , Surrey, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

30.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
5
Unique Violations
6/20/2023
Latest Refusal
6/20/2023
Earliest Refusal

Score Breakdown

Violation Severity
48.0×40%
Refusal Volume
11.2×30%
Recency
34.7×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

38641×

NCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
6/20/2023
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
320LACKS FIRM
3864NCONTACT
473LABELING
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Biologic Pharmamedical Research's FDA import refusal history?

Biologic Pharmamedical Research (FEI: 3016850308) has 1 FDA import refusal record(s) in our database, spanning from 6/20/2023 to 6/20/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Biologic Pharmamedical Research's FEI number is 3016850308.

What types of violations has Biologic Pharmamedical Research received?

Biologic Pharmamedical Research has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Biologic Pharmamedical Research come from?

All FDA import refusal data for Biologic Pharmamedical Research is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.